Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$320.5m
reported value
-12.8% vs Q1 2024
85positions
52.4%in top 10
17 new
13 added
22 reduced
14 sold out
vs Q1 2024
Options: 19 call positions ($173.3m notional), 9 put positions ($80.3m notional) – listed below, not included above.
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SAREPTA THERAPEUTICS INC SRPT | $32.2m10.04% | Added +51.3k |
| CRINETICS PHARMACEUTICALS IN CRNX | $26.4m8.23% | Reduced -54.9k |
| TARSUS PHARMACEUTICALS INC TARS | $21.8m6.79% | Added +90.0k |
| SOLENO THERAPEUTICS INC SLNO | $18.2m5.67% | Reduced -120.0k |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $14.0m4.37% | Reduced -249.7k |
| ENLIVEN THERAPEUTICS INC ELVN | $13.7m4.28% | New |
| AMGEN INC AMGN | $12.0m3.73% | New |
| NUVALENT INC COM | $11.5m3.59% | Added +50.0k |
| CYTOKINETICS INC CYTK | $9.2m2.88% | Added +25.0k |
| NURIX THERAPEUTICS INC NRIX | $9.2m2.87% | Added +140.5k |
| BRIDGEBIO PHARMA INC BBIO | $8.4m2.62% | Added +50.0k |
| CATALYST PHARMACEUTICALS INC CPRX | $8.0m2.51% | Unchanged |
| VIKING THERAPEUTICS INC VKTX | $7.3m2.29% | New |
| IMMUNOVANT INC IMVT | $7.3m2.28% | Unchanged |
| CARTESIAN THERAPEUTICS INC RNAC | $6.5m2.04% | New |
| ACELYRIN INC COM | $6.5m2.03% | Reduced -89.3k |
| NEUROCRINE BIOSCIENCES INC NBIX | $5.5m1.72% | New |
| PYXIS ONCOLOGY INC PYXS | $5.5m1.72% | Unchanged |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $4.6m1.42% | Reduced -100.0k |
| ROCKET PHARMACEUTICALS INC RCKT | $4.2m1.32% | Reduced -100.0k |
| XENON PHARMACEUTICALS INC XENE | $4.2m1.30% | Unchanged |
| CERVOMED INC CRVO | $4.1m1.27% | Unchanged |
| REZOLUTE INC RZLT | $3.9m1.21% | New |
| CYBIN INC COM | $3.8m1.18% | Unchanged |
| LENZ THERAPEUTICS INC LENZ | $3.5m1.10% | Added +119.5k |
| SILENCE THERAPEUTICS PLC SLN | $3.3m1.03% | New |
| INHIBRX BIOSCIENCES INC INBX | $3.3m1.02% | New |
| ABEONA THERAPEUTICS INC ABEO | $3.3m1.02% | Reduced -120.0k |
| INSMED INC INSM | $3.2m1.00% | Reduced -3.5k |
| TERNS PHARMACEUTICALS INC COM | $3.1m0.97% | Added +370.0k |
| VERONA PHARMA PLC VRNA | $2.9m0.91% | Reduced -174.2k |
| WAVE LIFE SCIENCES LTD 96663EUR | $2.9m0.90% | Reduced -15.0k |
| JASPER THERAPEUTICS INC JSPR | $2.4m0.74% | Unchanged |
| LARIMAR THERAPEUTICS INC LRMR | $2.3m0.73% | Reduced -115.0k |
| ARCUS BIOSCIENCES INC RCUS | $2.2m0.69% | New |
| Q32 BIO INC QTTB | $2.0m0.61% | Added +86.8k |
| ELEVATION ONCOLOGY INC COM | $1.9m0.58% | Added +542.0k |
| ANNEXON INC ANNX | $1.9m0.58% | Reduced -1.0m |
| COMPASS PATHWAYS PLC CMPS | $1.8m0.57% | New |
| NEKTAR THERAPEUTICS COM | $1.6m0.51% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $1.5m0.48% | Reduced -108.0k |
| SAGIMET BIOSCIENCES INC SGMT | $1.4m0.44% | Unchanged |
| TOURMALINE BIO INC TRML | $1.4m0.44% | Unchanged |
| IBIO INC IBIO | $1.3m0.40% | Unchanged |
| INFLARX NV IFRX | $1.2m0.38% | Unchanged |
| ACHILLES THERAPEUTICS PLC SPONSORED ADS | $1.2m0.37% | Unchanged |
| MIND MEDICINE MINDMED INC COM NEW | $1.2m0.37% | Reduced -135.0k |
| ITEOS THERAPEUTICS INC ITOS | $1.2m0.36% | Reduced -22.8k |
| KODIAK SCIENCES INC KOD | $1.1m0.35% | Unchanged |
| ROIVANT SCIENCES LTD ROIV | $1.1m0.33% | Unchanged |
| NUVATION BIO INC NUVB | $1.0m0.33% | Reduced -275.0k |
| TECTONIC THERAPEUTIC INC TECX | $1.0m0.32% | New |
| VENTYX BIOSCIENCES INC VTYX | $1.0m0.32% | Reduced -65.0k |
| ALLAKOS INC ALLKG | $972.7k0.30% | Added +40.0k |
| MACROGENICS INC MGNX | $850.3k0.27% | Reduced -118.1k |
| DELCATH SYS INC DCTH | $840.1k0.26% | New |
| MARINUS PHARMACEUTICALS INC MRNS | $826.2k0.26% | Added +168.2k |
| PROQR THRAPEUTICS N V PRQR | $802.7k0.25% | Unchanged |
| VERU INC COM | $796.2k0.25% | Unchanged |
| LYELL IMMUNOPHARMA INC COM | $762.8k0.24% | New |
| CLIMB BIO INC CLYM | $711.0k0.22% | New |
| AVALO THERAPEUTICS INC AVTX | $682.5k0.21% | Added +8.1k |
| ACUMEN PHARMACEUTICALS INC ABOS | $644.8k0.20% | Unchanged |
| MILESTONE PHARMACEUTICALS IN MIST | $619.8k0.19% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $610.8k0.19% | Unchanged |
| IMMATICS N.V IMTX | $574.2k0.18% | Unchanged |
| IMMUNIC INC COM | $547.8k0.17% | Reduced -1.1m |
| AMYLYX PHARMACEUTICALS INC AMLX | $521.6k0.16% | Reduced -56.9k |
| KEZAR LIFE SCIENCES INC COM | $521.4k0.16% | Unchanged |
| RAPT THERAPEUTICS INC COM | $471.6k0.15% | Unchanged |
| VOYAGER THERAPEUTICS INC VYGR | $441.8k0.14% | Reduced -125.0k |
| ANEBULO PHARMACEUTICALS INC ANEB | $431.0k0.13% | Unchanged |
| SENSEI BIOTHERAPEUTICS INC SNSE | $403.1k0.13% | New |
| PROTARA THERAPEUTICS INC TARA | $375.9k0.12% | Reduced -22.0k |
| NYXOAH S A NYXH | $356.9k0.11% | Unchanged |
| KARYOPHARM THERAPEUTICS INC COM | $355.2k0.11% | Unchanged |
| LYRA THERAPEUTICS INC LYRA | $292.4k0.09% | Unchanged |
| AEON BIOPHARMA INC CL A | $270.9k0.08% | Unchanged |
| TEMPEST THERAPEUTICS INC COM | $231.3k0.07% | Unchanged |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $196.3k0.06% | Unchanged |
| RELMADA THERAPEUTICS INC RLMD | $121.1k0.04% | Unchanged |
| STOKE THERAPEUTICS INC STOK | $92.1k0.03% | Unchanged |
| SYNLOGIC INC SYBX | $30.7k0.01% | Unchanged |
| BRAINSTORM CELL THERAPEUTICS COM NEW | $30.5k0.01% | Unchanged |
| CYTOMX THERAPEUTICS INC CTMX | $10.9k0.00% | New |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| ALPINE IMMUNE SCIENCES INC NVLS | $10.4m261.4k shares |
| PRAXIS PRECISION MEDICINES I PRAX | $10.3m168.4k shares |
| ALNYLAM PHARMACEUTICALS INC ALNY | $7.7m51.5k shares |
| UNIQURE NV QURE | $2.4m469.1k shares |
| APELLIS PHARMACEUTICALS INC APLS | $2.1m35.1k shares |
| ASTRIA THERAPEUTICS INC CATB | $2.0m140.7k shares |
| DISC MEDICINE INC IRON | $1.6m25.4k shares |
| AVROBIO INC | $965.2k754.1k shares |
| HOOKIPA PHARMA INC | $377.9k530.8k shares |
| EYEPOINT PHARMACEUTICALS INC EYPT | $21.6k1.0k shares |
| FINCH THERAPEUTICS GROUP INC | $18.1k6.9k shares |
| TYRA BIOSCIENCES INC TYRA | $8.2k501 shares |
| ASLAN PHARMACEUTICALS LTD | $6.3k35.4k shares |
| LONGBOARD PHARMACEUTICALS IN | $5.1k236 shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC ALNY · Put | $36.5m1.5k shares | Reduced |
| ALNYLAM PHARMACEUTICALS INC ALNY · Call | $36.5m1.5k shares | Reduced |
| INSMED INC INSM · Call | $34.0m5.1k shares | Reduced |
| AMGEN INC AMGN · Call | $18.7m600 shares | Reduced |
| PRAXIS PRECISION MEDICINES I PRAX · Put | $17.5m4.2k shares | New |
| SAREPTA THERAPEUTICS INC SRPT · Call | $15.8m1.0k shares | Reduced |
| BRIDGEBIO PHARMA INC BBIO · Call | $15.2m6.0k shares | Reduced |
| NEUROCRINE BIOSCIENCES INC NBIX · Call | $13.8m1.0k shares | New |
| PRAXIS PRECISION MEDICINES I PRAX · Call | $12.4m3.0k shares | Reduced |
| ALEXANDRIA REAL ESTATE EQ IN ARE · Put | $8.6m733 shares | Reduced |
| ASTRAZENECA PLC Call | $8.5m1.1k shares | Reduced |
| CORCEPT THERAPEUTICS INC CORT · Call | $6.0m1.9k shares | Reduced |
| INSMED INC INSM · Put | $4.8m709 shares | Reduced |
| VIRIDIAN THERAPEUTICS INC VRDN · Put | $3.6m2.8k shares | Reduced |
| ANNOVIS BIO INC ANVS · Put | $3.2m5.5k shares | Reduced |
| G1 THERAPEUTICS INC GTHX · Put | $2.9m12.9k shares | New |
| G1 THERAPEUTICS INC GTHX · Call | $2.8m12.2k shares | New |
| IMMUNOVANT INC IMVT · Call | $2.6m1.0k shares | New |
| SANA BIOTECHNOLOGY INC SANA · Call | $2.2m4.0k shares | New |
| SANA BIOTECHNOLOGY INC SANA · Put | $2.2m4.0k shares | New |
| VIRIDIAN THERAPEUTICS INC VRDN · Call | $1.3m1.0k shares | New |
| PYXIS ONCOLOGY INC PYXS · Call | $1.2m3.6k shares | New |
| STRUCTURE THERAPEUTICS INC GPCR · Call | $1.1m290 shares | Reduced |
| STRUCTURE THERAPEUTICS INC GPCR · Put | $1.1m290 shares | Reduced |
| RAPT THERAPEUTICS INC Call | $610.0k2.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |